Co-founded by Faheem Hasnain and Sheila Gujrathi, M.D., former executive leadership of Receptos, Inc. Omega Funds founding seed investor Series A co-led by ARCH Venture Partners and Omega Funds, $100 million in initial capital raised Pipeline of clinical and pre-clinical stage programs SAN DIEGO--(BUSINESS WIRE)--Receptos’ former executive leadership team, Faheem Hasnain and Sheila Gujrathi, M.D., today announced the launch of Gossamer Bio, Inc., a new biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products to address high unmet needs of targeted patient populations. Gossamer Bio’s strategy will be to leverage an asset-rich in-licen